Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Paul Bibeau, VP Business Development, Acquires 100,000 Shares

Re: Paul Bibeau, VP Business Development, Acquires 100,000 Shares

posted on Jan 31, 2009 07:18AM

wish I paid what he paid for 100, 000 shares!

Share
New Message
Please login to post a reply